NYSE and NASDAQ Stock Price Targets and Analyst Ratings

→ Historic NVIDIA partnership could send this tiny AI stock soaring... (From Behind the Markets) (Ad)

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAN Aaron's	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.02 -0.4%	$8.00 ➝ $10.10	Hold ➝ Hold
AAN Aaron's	Target Raised by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.02 -0.4%	$8.00 ➝ $10.00	Hold ➝ Hold
AAPL Apple	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$214.29 -1.1%	$225.00 ➝ $245.00	Overweight ➝ Overweight
ABBV AbbVie	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$171.35 +1.0%	$185.00 ➝ $190.00	Overweight ➝ Overweight
ACLX Arcellx	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$53.81 +0.1%	$87.00 ➝ $87.00	Buy ➝ Buy
ACN Accenture	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$285.34 -0.1%	$398.00 ➝ $350.00	Buy ➝ Buy
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
ADSK Autodesk	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$244.12 +1.5%	$260.00 ➝ $260.00	Outperform ➝ Outperform
ADSK Autodesk	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$244.12 +1.5%	$275.00 ➝ $275.00	Outperform ➝ Outperform
ADUS Addus HomeCare	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$119.30 +1.4%	$119.00 ➝ $128.00	Buy ➝ Buy
ALV Autoliv	Initiated by	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating		$108.80 -2.9%		Neutral
AMRN Amarin	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.73 -3.9%		Overweight
AMTB Amerant Bancorp	Initiated by	Janney Montgomery Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.19 -1.9%	$25.00	Buy
AON AON	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$297.90 -0.7%	$315.00 ➝ $315.00	Sector Perform ➝ Sector Perform
AVTE Aerovate Therapeutics	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.41 -14.5%	$35.00 ➝ $2.00	Overweight ➝ Equal Weight
AVTE Aerovate Therapeutics	Downgraded by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.41 -14.5%		Buy ➝ Hold
AVTE Aerovate Therapeutics	Downgraded by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.41 -14.5%	$27.00 ➝ $2.00	Outperform ➝ Inline
AYI Acuity Brands	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$250.04 -3.5%	$286.00 ➝ $280.00	Neutral ➝ Neutral
AZEK AZEK	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$46.76 +0.2%	$57.00 ➝ $57.00	Buy ➝ Buy
BHVN Biohaven	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.77 -0.7%	$59.00 ➝ $59.00	Outperform ➝ Outperform
BILI Bilibili	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.18 +3.0%	$21.00	Neutral ➝ Overweight
BSX Boston Scientific	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$76.34 +0.2%	$82.00 ➝ $82.00	Buy ➝ Buy
BXMT Blackstone Mortgage Trust	Reiterated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.93	$18.00 ➝ $18.00	Market Perform ➝ Market Perform
BYON Beyond	Target Lowered by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.77 +1.7%	$19.00 ➝ $15.50	Neutral ➝ Neutral
CATX Perspective Therapeutics	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.93 +15.4%		Outperform ➝ Outperform
CATX Perspective Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.93 +15.4%		Overweight
CDLX Cardlytics	Initiated by	Northland Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.21 -0.5%	$14.00	Outperform
CELH Celsius	Target Lowered by	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.28 +8.3%	$110.00 ➝ $90.00	Buy ➝ Buy
CGNT Cognyte Software	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.60 -5.1%		Hold
CHGG Chegg	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.70 +3.4%		Hold
CLDX Celldex Therapeutics	Initiated by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.66 -0.7%	$58.00	Buy
CLDX Celldex Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.66 -0.7%	$67.00 ➝ $67.00	Overweight ➝ Overweight
CLNN Clene	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.38 +2.7%	$7.00 ➝ $7.00	Buy ➝ Buy
CLSK CleanSpark	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.48 +1.2%	$27.00 ➝ $27.00	Buy ➝ Buy
CMG Chipotle Mexican Grill	Target Raised by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3,427.82 +1.9%	$3,668.00 ➝ $3,888.00	Buy ➝ Buy
COIN Coinbase Global	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$235.95 -3.7%	$315.00 ➝ $315.00	Buy ➝ Buy
CPA Copa	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$95.61 -0.8%	$160.00 ➝ $145.00	Buy
CRH CRH	Initiated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$77.85 -1.1%	$95.00	Overweight
CSGP CoStar Group	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$72.73 -0.6%	$110.00 ➝ $110.00	Market Outperform ➝ Market Outperform
CTVA Corteva	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$51.91 -0.2%	$61.00 ➝ $60.00	Buy ➝ Buy
DAY Dayforce	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$49.14 -1.8%	$72.00 ➝ $66.00	Buy ➝ Buy
[Urgent] Protect your money before November (Ad) Those who listened to his warnings could have kept their money safe and even made substantial profits during each crisis. In fact, the Wall Street Journal reported that his work was more accurate … and more profitable than that of … Deutsche Bank … Merrill Lynch … JPMorgan Chase … Goldman Sachs … and every other firm reviewed. Click here to watch now.
DBRG DigitalBridge Group	Reiterated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.31 -1.5%	$21.00 ➝ $17.00	Buy
DBRG DigitalBridge Group	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.31 -1.5%	$18.50 ➝ $17.75	Outperform ➝ Outperform
DT Dynatrace	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$43.26 -4.7%		Hold
EDIT Editas Medicine	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.04 -0.6%	$12.00 ➝ $12.00	Market Perform ➝ Market Perform
ELF e.l.f. Beauty	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$213.67 +9.3%	$214.00 ➝ $250.00	Buy
ELF e.l.f. Beauty	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$213.67 +9.3%	$214.00 ➝ $250.00	Buy ➝ Buy
ELUT Elutia	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.27 +2.8%	$5.00 ➝ $11.00	Overweight ➝ Overweight
EQH Equitable	Downgraded by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$40.03 0.0%	$40.00 ➝ $43.00	Buy ➝ Neutral
ET Energy Transfer	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.50 +1.1%	$19.00 ➝ $20.00	Buy ➝ Buy
FC Franklin Covey	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.12 -0.8%	$45.00 ➝ $45.00	Outperform ➝ Outperform
FSLR First Solar	Downgraded by	Janney Montgomery Scott Subscribe to MarketBeat All Access for the recommendation accuracy rating		$262.37 +0.4%		Buy ➝ Neutral
GLW Corning	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Roberts Subscribe to MarketBeat All Access for the recommendation accuracy rating	$40.21 +3.8%	$36.00 ➝ $42.00	Neutral ➝ Neutral
HLLY Holley	Reiterated by	Benchmark Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.36 +3.1%	$12.00 ➝ $12.00	Buy ➝ Buy
HMN Horace Mann Educators	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.35 +0.9%		Market Perform
HMST HomeStreet	Reiterated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.50 +3.4%	$13.50 ➝ $13.50	Market Perform ➝ Market Perform
HSY Hershey	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$182.72 -0.2%	$210.00 ➝ $204.00	Equal Weight ➝ Equal Weight
IMVT Immunovant	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$26.19 -2.3%		Overweight
INCY Incyte	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$61.44 -2.0%		Neutral
INVA Innoviva	Initiated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.22 +0.4%		Overweight
ITCI Intra-Cellular Therapies	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$75.48 +9.6%	$90.00 ➝ $94.00	Buy ➝ Buy
JNPR Juniper Networks	Upgraded by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.56 +0.2%	$40.00	Hold ➝ Buy
JSPR Jasper Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$23.19 -4.6%		Overweight
KALV KalVista Pharmaceuticals	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.37 -3.8%	$35.00 ➝ $35.00	Buy ➝ Buy
KMB Kimberly-Clark	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$141.67 +0.9%	$165.00 ➝ $165.00	Outperform ➝ Outperform
KMX CarMax	Target Lowered by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$71.49 -0.3%	$75.00 ➝ $72.00	Neutral ➝ Neutral
KMX CarMax	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$71.49 -0.3%	$90.00 ➝ $90.00	Outperform ➝ Outperform
KMX CarMax	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$71.49 -0.3%	$72.00 ➝ $66.00	Hold ➝ Hold
KNF Knife River	Initiated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$71.45 +1.4%	$85.00	Overweight
KOPN Kopin	Initiated by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.71 +1.4%	$2.50	Buy
KR Kroger	Upgraded by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$51.98 +1.8%	$58.00 ➝ $60.00	Market Perform ➝ Outperform
KROS Keros Therapeutics	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.65 +0.2%	$100.00 ➝ $100.00	Buy ➝ Buy
KROS Keros Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$44.65 +0.2%	$100.00 ➝ $100.00	Buy ➝ Buy
KURA Kura Oncology	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.77 -4.4%	$32.00 ➝ $32.00	Market Outperform ➝ Market Outperform
LEN Lennar	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Mccanless Subscribe to MarketBeat All Access for the recommendation accuracy rating	$148.76 -5.0%	$144.00 ➝ $144.00	Underperform ➝ Underperform
LEN Lennar	Reiterated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$148.76 -5.0%	$183.00 ➝ $183.00	Outperform ➝ Outperform
LEVI Levi Strauss & Co.	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$23.53 +0.2%	$23.00 ➝ $26.00	Buy ➝ Buy
MIRM Mirum Pharmaceuticals	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$29.25 -11.4%	$38.00 ➝ $64.00	Buy ➝ Buy
MIRM Mirum Pharmaceuticals	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$29.25 -11.4%	$31.00 ➝ $39.00	Overweight ➝ Overweight
MIRM Mirum Pharmaceuticals	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$29.25 -11.4%	$53.00 ➝ $57.00	Overweight ➝ Overweight
MIRM Mirum Pharmaceuticals	Target Raised by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$29.25 -11.4%	$66.00 ➝ $68.00	Market Outperform ➝ Market Outperform
MRK Merck & Co., Inc.	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Chen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$127.99 +0.4%	$155.00 ➝ $155.00	Overweight ➝ Overweight
MRNS Marinus Pharmaceuticals	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.40 -3.5%	$10.00 ➝ $10.00	Buy ➝ Buy
MRNS Marinus Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.40 -3.5%	$11.00 ➝ $11.00	Buy ➝ Buy
MU Micron Technology	Target Raised by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$153.45 +3.8%	$130.00 ➝ $170.00	Outperform ➝ Outperform
MU Micron Technology	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$153.45 +3.8%	$140.00 ➝ $165.00	Buy ➝ Buy
NFLX Netflix	Target Raised by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$685.67 +1.5%	$700.00 ➝ $750.00	Buy ➝ Buy
NI NiSource	Reiterated by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.07 +0.3%	$31.00 ➝ $31.00	Outperform ➝ Outperform
NOC Northrop Grumman	Target Lowered by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$425.87 -0.9%	$530.00 ➝ $500.00	Hold ➝ Hold
NOC Northrop Grumman	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$425.87 -0.9%	$483.00 ➝ $518.00
NOW ServiceNow	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$730.38 +0.7%	$900.00 ➝ $900.00	Buy ➝ Buy
[Urgent] Protect your money before November (Ad) Those who listened to his warnings could have kept their money safe and even made substantial profits during each crisis. In fact, the Wall Street Journal reported that his work was more accurate … and more profitable than that of … Deutsche Bank … Merrill Lynch … JPMorgan Chase … Goldman Sachs … and every other firm reviewed. Click here to watch now.
NRIX Nurix Therapeutics	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.44 +20.6%	$19.00 ➝ $26.00	Buy ➝ Buy
NTLA Intellia Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.80 -1.5%	$65.00 ➝ $65.00	Overweight ➝ Overweight
NVDA NVIDIA	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$135.58 +3.5%	$125.00 ➝ $155.00	Overweight ➝ Overweight
NVDA NVIDIA	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$135.58 +3.5%	$140.00 ➝ $200.00	Buy ➝ Buy
NVDA NVIDIA	Target Raised by	Tigress Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$135.58 +3.5%	$98.50 ➝ $170.00	Buy ➝ Buy
OGE OGE Energy	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.11 -0.1%	$34.00 ➝ $35.00	Equal Weight ➝ Equal Weight
OMGA Omega Therapeutics	Initiated by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.22 +19.4%	$12.00	Outperform
ONON ON	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Civello Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.24 +1.5%	$46.00 ➝ $46.00	Buy ➝ Buy
ORCL Oracle	Target Raised by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$144.64 +2.4%	$145.00 ➝ $159.00	Buy ➝ Buy
ORRF Orrstown Financial Services	Reiterated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.33 -0.3%	$32.00 ➝ $32.00	Outperform ➝ Outperform
OVID Ovid Therapeutics	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.79	$11.00 ➝ $5.00	Buy ➝ Buy
OVID Ovid Therapeutics	Target Lowered by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.79	$9.00 ➝ $3.00	Buy ➝ Buy
OVID Ovid Therapeutics	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.79	$3.50 ➝ $1.20	Neutral ➝ Neutral
OVID Ovid Therapeutics	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Selvaraju Subscribe to MarketBeat All Access for the recommendation accuracy rating	$0.79	$9.00 ➝ $3.00	Buy ➝ Buy
OVID Ovid Therapeutics	Downgraded by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.79		Outperform ➝ Market Perform
PAYC Paycom Software	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$141.46 -1.0%	$193.00 ➝ $162.00	Neutral ➝ Neutral
PCTY Paylocity	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$133.87 -3.0%	$225.00 ➝ $195.00	Outperform ➝ Outperform
PCTY Paylocity	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$133.87 -3.0%	$178.00 ➝ $155.00	Neutral ➝ Neutral
POOL Pool	Target Lowered by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$337.89 -1.5%	$415.00 ➝ $370.00	Hold ➝ Hold
PPC Pilgrim's Pride	Initiated by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.53 +2.3%	$41.00	Buy
PRAX Praxis Precision Medicines	Initiated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.69 +3.1%	$155.00	Buy
PRMW Primo Water	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.17 -2.7%	$24.00 ➝ $26.00	Overweight ➝ Overweight
PRMW Primo Water	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.17 -2.7%	$30.00 ➝ $30.00	Outperform ➝ Outperform
PRMW Primo Water	Target Raised by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.17 -2.7%	$30.00 ➝ $32.00	Buy
PRMW Primo Water	Target Raised by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.17 -2.7%	$24.00 ➝ $26.00	Outperformer ➝ Outperformer
PYCR Paycor HCM	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.15 -3.0%	$17.00 ➝ $14.00	Neutral ➝ Neutral
PYPD PolyPid	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.11 -1.7%	$14.00 ➝ $14.00	Buy ➝ Buy
QGEN Qiagen	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$43.75 +0.0%	$52.00 ➝ $54.00	Overweight ➝ Overweight
QNST QuinStreet	Upgraded by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.21 +4.0%	$22.00	Hold ➝ Buy
QTWO Q2	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$57.86 -0.2%	$65.00 ➝ $68.00	Buy ➝ Buy
RBA RB Global	Initiated by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$80.03 -0.5%	$95.00	Sector Outperform
RDDT Reddit	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		60.21 -0.2%	$63.00 ➝ $75.00	Buy ➝ Buy
RGEN Repligen	Initiated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$123.00 -1.1%		Neutral
RKLB Rocket Lab USA	Reiterated by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.91 +13.1%	$7.00 ➝ $7.00	Buy ➝ Buy
ROIV Roivant Sciences	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.84 +1.1%		Overweight
SILK Silk Road Medical	Reiterated by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.88 +24.0%	$28.00 ➝ $27.50	Buy ➝ Hold
SRAD Sportradar Group	Initiated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.64 -2.7%	$12.00	Neutral
STLD Steel Dynamics	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$125.00 -1.2%	$140.00 ➝ $135.00	Market Perform ➝ Market Perform
STM STMicroelectronics	Upgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$43.07 -0.1%	$35.50 ➝ $45.80	Sell ➝ Neutral
STNG Scorpio Tankers	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$80.74 +3.0%	$82.00 ➝ $85.00	Neutral ➝ Neutral
SUN Sunoco	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$54.51 -0.2%	$65.00	Neutral ➝ Buy
T AT&T	Reiterated by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.07 +2.3%	$24.00 ➝ $24.00	Buy ➝ Buy
TER Teradyne	Target Raised by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$151.75 +4.8%	$130.00 ➝ $170.00	Buy ➝ Buy
TFIN Triumph Financial	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$77.60 +0.4%	$68.00 ➝ $75.00	Market Perform ➝ Market Perform
TPR Tapestry	Reiterated by	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.01 -2.2%	$52.00 ➝ $52.00	Buy ➝ Buy
TPVG TriplePoint Venture Growth BDC	Reiterated by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.82 +0.8%	$9.00 ➝ $9.00	Underperform ➝ Underperform
TSHA Taysha Gene Therapies	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.97 -26.3%	$7.00 ➝ $7.00	Buy ➝ Buy
URBN Urban Outfitters	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$45.11 +1.4%	$50.00 ➝ $52.00	Overweight ➝ Overweight
VSAT Viasat	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.20 -5.8%	$28.00 ➝ $26.00	Equal Weight ➝ Equal Weight
VZLA Vizsla Silver	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.74 +5.5%	$3.25 ➝ $3.50	Buy ➝ Buy
Historic NVIDIA partnership could send this tiny AI stock soaring... (Ad) After striking partnerships with trillion-dollar chipmaker NVIDIA... ARM surged over 60% in a week... Who's next? Click here to discover the name and ticker symbol >>>
WDFC WD-40	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$224.47 -0.1%	$313.00 ➝ $313.00	Buy ➝ Buy
WING Wingstop	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$428.85 +2.7%	$420.00 ➝ $460.00	Buy ➝ Buy
WMB Williams Companies	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.83 +1.4%	$40.00 ➝ $42.00	Hold ➝ Hold
WOLF Wolfspeed	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.01 -4.0%	$27.00 ➝ $28.00	Neutral ➝ Neutral
XENE Xenon Pharmaceuticals	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$36.25 -1.0%	$55.00 ➝ $55.00	Outperform ➝ Outperform
XPOF Xponential Fitness	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.05 -0.5%	$18.00 ➝ $20.00	Buy ➝ Buy
ZG Zillow Group	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$47.55 +4.4%	$52.00 ➝ $52.00	Buy ➝ Buy
ZNTL Zentalis Pharmaceuticals	Downgraded by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.14 -50.7%	$15.00 ➝ $4.00	Neutral ➝ Underperform
ZNTL Zentalis Pharmaceuticals	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.14 -50.7%	$29.00 ➝ $9.00	Overweight ➝ Equal Weight
ZNTL Zentalis Pharmaceuticals	Target Lowered by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.14 -50.7%	$50.00 ➝ $25.00	Outperform ➝ Outperform
ZNTL Zentalis Pharmaceuticals	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.14 -50.7%	$38.00 ➝ $8.00	Overweight ➝ Equal Weight
ZNTL Zentalis Pharmaceuticals	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.14 -50.7%	$42.00 ➝ $6.00	Buy ➝ Hold
ZNTL Zentalis Pharmaceuticals	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.14 -50.7%	$32.00 ➝ $10.00	Buy ➝ Buy
ZNTL Zentalis Pharmaceuticals	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.14 -50.7%	$40.00 ➝ $20.00	Buy ➝ Buy
ZUO Zuora	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.36 -1.5%	$15.00 ➝ $15.00	Buy ➝ Buy